Search results for "Blood"

showing 10 items of 5199 documents

Cardiovascular risk in psoriatic arthritis, a narrative review

2020

Abstract Introduction Psoriatic arthritis (PsA) is a chronic inflammatory rheumatism characterized for a long time by a high degree of cardiovascular risk. Chronic inflammation is one of the mechanisms that explain this cardiovascular excess of risk through direct and indirect pathways. In recent years, epidemiological data have changed somewhat since the increasing use of bio-drugs that are effective in reducing this inflammation. The purpose of this review is to assess the current state of cardiovascular morbidity and mortality in PsA and thus to assess the cardiovascular risk in case of PsA. Method We conducted a literature review using Pubmed and Medline databases with the following key…

medicine.medical_specialty03 medical and health sciencesPsoriatic arthritis0302 clinical medicineInsulin resistanceRheumatologyRisk FactorsDiabetes mellitusInternal medicineEpidemiologymedicineHumansPsoriasisProspective Studies030212 general & internal medicineProspective cohort study030203 arthritis & rheumatologybusiness.industryArthritis Psoriaticmedicine.diseaseBlood pressureCardiovascular DiseasesHeart Disease Risk FactorsMetabolic syndromebusinessDyslipidemiaJoint Bone Spine
researchProduct

Does the renin-angiotensin system also regulate intra-ocular pressure?

2009

The renin-angiotensin-aldosterone system is known to play an essential role in controlling sodium balance and body fluid volumes, and thus blood pressure. In addition to the circulating system which regulates urgent cardiovascular responses, a tissue-localized renin-angiotensin system (RAS) regulates long-term changes in various organs. Many recognized RAS components have also been identified in the human eye. The highly vasoconstrictive angiotensin II (Ang II) is considered the key peptide in the circulatory RAS. However, the ultimate effect of RAS activation at tissue level is more complex, being based not only on the biological activity of Ang II but also on the activities of other produ…

medicine.medical_specialty030204 cardiovascular system & hematologyPeptide hormoneRenin-Angiotensin System03 medical and health sciences0302 clinical medicineInternal medicineRenin–angiotensin systemMedicineAnimalsHumansIntraocular Pressurebiologybusiness.industryAngiotensin-converting enzymeBiological activityGeneral MedicineWater-Electrolyte BalanceAngiotensin IIBiosynthetic PathwaysBlood pressureEndocrinologyACE inhibitorCirculatory system030221 ophthalmology & optometrybiology.proteinOcular Hypertensionbusinessmedicine.drugAnnals of medicine
researchProduct

Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study amo…

2011

Objectives To investigate the association between increase in physical activity and changes in cardiometabolic risk factors during a lifestyle intervention programme in routine clinical settings. Design Prospective follow-up. Setting 400 primary healthcare centres and occupational healthcare outpatient clinics in Finland. Participants Individuals at high risk for type 2 diabetes identified in the implementation project of the national diabetes prevention programme (FIN-D2D) and participating in baseline and 1-year follow-up visits. Final study group comprised the 1871 non-diabetic participants who responded at follow-up visit to a question on stability versus increase of physical activity. …

medicine.medical_specialty1688Psychological intervention030209 endocrinology & metabolismType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusHealth caremedicine1724Outpatient clinic15061704030212 general & internal medicine1696business.industryResearchPublic healthHealth services researchGeneral Medicinemedicine.disease3. Good healthDiabetes and EndocrinologyBlood pressurePhysical therapy1736businessBMJ Open
researchProduct

The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEGlobal HealthArticleBetacoronavirusInternal medicinePandemicGlobal healthMedicineHumansMortalityBlood CoagulationPandemicsbiologybusiness.industrySARS-CoV-2AnticoagulantsCOVID-19Thrombosismedicine.diseasebiology.organism_classificationVirologySurvival RatePneumoniaMeta-analysisCardiologyCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsBetacoronavirusThe American journal of cardiology
researchProduct

Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis

2012

Autosomal recessive renal tubular dysgenesis (RTD) is a severe disorder of renal tubular development characterized by early onset and persistent fetal anuria leading to oligohydramnios and the Potter sequence, associated with skull ossification defects. Early death occurs in most cases from anuria, pulmonary hypoplasia, and refractory arterial hypotension. The disease is linked to mutations in the genes encoding several components of the renin-angiotensin system (RAS): AGT (angiotensinogen), REN (renin), ACE (angiotensin-converting enzyme), and AGTR1 (angiotensin II receptor type 1). Here, we review the series of 54 distinct mutations identified in 48 unrelated families. Most of them are no…

medicine.medical_specialty2716 Genetics (clinical)10039 Institute of Medical GeneticsAngiotensinogen030232 urology & nephrologyGenes RecessivePrenatal diagnosis610 Medicine & healthPeptidyl-Dipeptidase ABiologymedicine.disease_causeReceptor Angiotensin Type 1Kidney Tubules ProximalRenin-Angiotensin System03 medical and health sciences0302 clinical medicine1311 GeneticsInternal medicineReninRenin–angiotensin systemGeneticsmedicineAnimalsHumansGenetic Association StudiesGenetics (clinical)030304 developmental biology0303 health sciencesKidneyMutationAngiotensin II receptor type 1medicine.disease3. Good healthDisease Models Animalmedicine.anatomical_structureEndocrinologyUrogenital AbnormalitiesRenal blood flowMutation570 Life sciences; biologyAnuriamedicine.symptomPotter sequence
researchProduct

Severe plasma prekallikrein deficiency : clinical characteristics, novel KLKB1 mutations, and estimated prevalence

2020

BACKGROUND Severe plasma prekallikrein (PK) deficiency is an autosomal-recessive defect characterized by isolated activated partial thromboplastin time prolongation. To date, no comprehensive methodologically firm analysis has investigated the diagnostic, clinical, and genetic characteristics of PK deficiency, and its prevalence remains unknown. PATIENTS/METHODS We described new families with PK deficiency, retrieved clinical and laboratory information of cases systematically searched in the (gray) literature, and collected blood of these cases for complementary analyses. The Genome Aggregation Database (gnomAD) and the population-based Gutenberg Health Study served to study the prevalence …

medicine.medical_specialty2720 HematologyPopulation610 Medizin610 Medicine & healthReference range030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePlasma PrekallikreinInternal medicine610 Medical sciencesPrevalenceHumansMedicineeducation610 Medicine & healthFactor XIIeducation.field_of_studymedicine.diagnostic_testbusiness.industry10031 Clinic for AngiologyPrekallikreinPrekallikreinHematologyBlood Coagulation Disordersmedicine.diseaseThrombosisMutation10032 Clinic for Oncology and HematologyCohortbusinessPartial thromboplastin time
researchProduct

Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women

2020

Abstract In addition to governing key functions in bone metabolism and the immune system, the RANK/RANKL/OPG system plays a role in the vascular system, particularly in vascular calcification and atherosclerosis. Given that these 2 phenotypes are considered a major cause of high blood pressure (BP), in this study we analyzed the association of SNPs in RANK and OPG genes with blood pressure. An observational study was conducted of 2 SNPs in the RANK gene (rs884205 and rs78326403) and 1 in the OPG gene (rs4876869) with systolic (SBP) and diastolic blood pressure (DBP) in a cohort of 695 women. Data analysis revealed a statistically significant association between the SNP rs884205 and BP press…

medicine.medical_specialty3400Observational StudySingle-nucleotide polymorphismGenome-wide association studyassociation studyPolymorphism Single NucleotidepolymorphismRANK and osteoprotegerin genes03 medical and health sciencessymbols.namesake0302 clinical medicinePolymorphism (computer science)Internal medicineGenotypeHumansMedicineSNP030212 general & internal medicineAlleleReceptor Activator of Nuclear Factor-kappa Bbusiness.industryOsteoprotegerinblood pressureGeneral MedicineMiddle AgedEndocrinologyBonferroni correctionBlood pressureSpain030220 oncology & carcinogenesissymbolsFemalebusinessGenome-Wide Association StudyResearch ArticleMedicine
researchProduct

2020

Background: ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) are co-localized at the blood-brain barrier (BBB), where they restrict the brain distribution of many different drugs. Moreover, ABCB1 and possibly ABCG2 play a role in Alzheimer’s disease (AD) by mediating the brain clearance of beta-amyloid (Aβ) across the BBB. This study aimed to compare the abundance and activity of ABCG2 in a commonly used β-amyloidosis mouse model (APP/PS1-21) with age-matched wild-type mice. Methods: The abundance of ABCG2 was assessed by semi-quantitative immunohistochemical analysis of brain slices of APP/PS1-21 and wild-type mice aged 6 months. Moreover, the brain distribution of two d…

medicine.medical_specialtyAbcg2TariquidarBlood–brain barrierCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineInternal medicinemental disordersmedicineDistribution (pharmacology)Physical and Theoretical ChemistryMolecular BiologySpectroscopy030304 developmental biology0303 health sciencesbiologymedicine.diagnostic_testChemistryAmyloidosisOrganic ChemistryGeneral Medicinemedicine.diseaseComputer Science Applicationsmedicine.anatomical_structureEndocrinologyPositron emission tomographyembryonic structuresbiology.proteinImmunohistochemistrysense organsErlotinib030217 neurology & neurosurgerymedicine.drugInternational Journal of Molecular Sciences
researchProduct

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges

2020

AbstractHemophilia A (HA) and B (HB) are X-linked bleeding disorders caused by mutations in the F8 or F9 gene that result in the absence, or reduced activity, of the corresponding clotting factor. The severity of bleeding and related complications is proportional to the amount of residual circulating functional factor. The development of a safe and effective hemophilia treatment lasted several decades and has been mainly based on clotting factor replacement. Advances in the engineering and manufacturing of clotting concentrates have led to the widespread availability of extended half-life products that reduced the number of intravenous infusions needed to achieve adequate trough levels. The…

medicine.medical_specialtyAcetylgalactosamineInjections SubcutaneousLipoproteinsHemorrhage030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedHemophilia AHemophilia BSeverity of Illness IndexDisease courseFactor IX03 medical and health sciencesRoute of administrationLife Expectancy0302 clinical medicineAntibodies BispecificmedicineHumansRNA Small InterferingInfusions IntravenousIntensive care medicineFactor IXClotting factorClinical Trials as TopicFactor VIIICoagulantsbusiness.industryGenetic TherapyHematologyIntravenous InfusionsHistory 20th CenturyBlood Coagulation FactorsLaboratoriesbusiness030215 immunologymedicine.drugHämostaseologie
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct